Get the Latest Information on COVID-19 for Myeloma Patients
Know your COVID-19 Community Level, read up on the IMF's latest recommendations and answers to FAQs on COVID-19 vaccines, boosters, anti-viral treatments, and more.
Read up on the IMF's latest recommendations and answers to FAQs on COVID-19 vaccines, boosters, anti-viral treatments and other relevant COVID-19 related information for patients who have multiple myeloma (MM), smoldering multiple myeloma (SMM), or monoclonal gammopathy of undetermined significance (MGUS).
Use the COVID-19 Community Levels Tool* to utilize the latest data and help your community decide on the best prevention steps to take. Levels can be low, medium, or high and are based on the following:
- Number of hospital beds being used
- Hospital admissions
- Total number of new COVID-19 cases in an area
(*Maps, charts, and data are provided by the CDC, with updates every Thursday by 8 pm ET)
The IMF highly recommends these safety tips from the CDC for myeloma patients. Read up on CDC recommendations for the moderately or severely immunocompromised, building a personal COVID-19 plan, proper ventilation, and more.
- World Health Organization
- Centers for Disease Control
- COVID-19 Emergency Declarations to End on May 11
- FDA to Require Diversity Plan for Clinical Trials
- U.S. Government Response
- Global Dashboard of Confirmed Cases
- Medicare Current Emergencies
- Watch Out for Medicare Fraud (Possible COVID-19 Scams)
- VA and Coronavirus
- The American Red Cross: Coronavirus Safety for People at Higher Risk
- Multiple Myeloma Medicare Access
- Healthwell Foundation COVID-19 Ancillary Costs Support